Latest News
Conference Coverage
Experts elevate new drugs for diabetic kidney disease
A consensus statement from the ADA and KDIGO recommends more aggressive combined use of several newer, and costly, drug classes to slow...
Conference Coverage
Diabetes tied to risk of long COVID, too
Roughly 43% of studies in a literature review identified diabetes as a risk factor for postacute sequelae of COVID-19.
Conference Coverage
Air pollution tied to ventricular arrhythmias in those with ICDs
Researchers found that vulnerable patients with ICDs experienced more ventricular arrhythmias on days with higher levels of air pollution.
Guidelines
New National Lipid Association statement on statin intolerance
The statement offers strategies to help patients stay on statin medications and suggests alternatives that can be used in patients who really...
Conference Coverage
Nonhormonal drug for menopause symptoms passes phase 3 test
The novel NK3 receptor–inhibitor fezolinetant controlled vasomotor symptoms of menopause over 52 weeks in the phase 3 SKYLIGHT 2 trial.
Conference Coverage
Exercise of any type boosts type 1 diabetes time in range
Aerobic, interval, and resistance training all were significantly associated with improved glucose time in range, compared to no exercise.
From the Journals
‘Forever chemicals’ linked to hypertension in middle-aged women
“The benefit of reducing the population exposure to PFAS and potential prevention of high blood pressure and other health conditions would be...
From the Journals
Surgery during a pandemic? COVID vaccination status matters – or not
Feature
Cause of death in pig heart recipient: New clues
New details on efforts to identify the mechanism of David Bennett’s death tentatively rule out a few possible suspects that had been at the top of...
Conference Coverage
Prediabetes is linked independently to myocardial infarction
A history of prediabetes is predictor of MI independent of any other risk factor, suggesting that screening efforts should increase.
Conference Coverage
Avexitide promising for hypoglycemia after weight-loss surgery
The GLP-1 receptor antagonist reduced all levels of hypoglycemia, by different measures, and in patients who had undergone different bariatric...